TWENTY represents a significant milestone for Aerogen in our 25th year of business - the production of our 20 millionth Aerogen Solo.
TWENTY represents a significant milestone for Aerogen in our 25th year of business - the production of our 20 millionth Aerogen Solo.
In 2023 we produced our 20 millionth Aerogen Solo. This moment marks a significant milestone in the growth of Aerogen over the last 25 years. We have treated patients in over 75 countries, employed over 500 people and now our 20 millionth Aerogen Solo is out there alongside all the others. Helping to treat patients in hospitals, worldwide.
CEO and Founder John Power shared some words at this momentous occasion "Our journey has been marked by relentless dedication to innovation led and customer-centric solutions and whilst we today rightly celebrate a production milestone, we also reflect on the acutely sick patients those products have played a key role in treating. To be able to impact the clinical outcome for one person is a great privilege, to be involved in the treatment of 20 million individual patients globally is not alone a huge privilege but also an incredible honour for us all at Aerogen".
We wanted to give back, but how? The 20 millionth Aerogen Solo was packaged in a distinctive, gold-branded box. Our winner was Klinkum Dortmund in Germany. They were acknowledged with a generous €10,000 donation to their registered hospital charity or a charity of their choosing (T&C apply).
